Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs01:25

Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs

2.3K
Asthma is a chronic respiratory condition for which new therapeutic avenues, including anti-inflammatory drugs like mast cell stabilizers and anti-IgE treatments, continue to be developed.
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
2.3K
Antiasthma Drugs: Leukotriene Modifiers01:19

Antiasthma Drugs: Leukotriene Modifiers

2.2K
Leukotriene modifiers, or cysteinyl leukotriene receptor antagonists, are medications used to manage chronic asthma. These agents target specific inflammatory mediators produced during arachidonic acid metabolism, an essential process in generating inflammation in the body.
Leukotriene modifiers work through two distinct mechanisms:
2.2K
Antiasthma Drugs: Methylxanthines01:24

Antiasthma Drugs: Methylxanthines

2.0K
Theophylline, a member of the methylxanthine class of bronchodilators, has long been used in asthma management. While its exact mechanism of action is not fully understood, it is believed to have multiple effects on various cellular processes.
Theophylline is thought to inhibit phosphodiesterase enzymes, increasing intracellular levels of cyclic adenosine monophosphate (cAMP) and cyclic guanosine monophosphate (cGMP). This rise in cAMP and cGMP concentrations stimulates cardiac function,...
2.0K
Antiasthma Drugs: Muscarinic Receptor Antagonists01:20

Antiasthma Drugs: Muscarinic Receptor Antagonists

2.1K
Muscarinic receptor antagonists, also known as antimuscarinic agents, are a class of bronchodilators used to treat asthma, although they are more commonly used to treat COPD. They work by inhibiting the action of acetylcholine (ACh), a neurotransmitter, on muscarinic receptors found in the airways.
Antimuscarinic agents compete with ACh for the same binding site on the muscarinic receptors. By binding to these receptors, they inhibit the downstream effects of ACh and block the parasympathetic...
2.1K
Drugs Used in Lower Respiratory Disorders: Overview01:17

Drugs Used in Lower Respiratory Disorders: Overview

1.5K
Lower respiratory tract disorders present challenges that often require skilled and nuanced approaches for effective management. Common ailments, such as asthma and chronic obstructive pulmonary disease (COPD), have prompted the development of intricate treatment strategies involving bronchodilators and anti-inflammatory drugs, each tailored to ease breathing and revitalize the lungs.
Bronchodilators, the first step of respiration enhancement, come in various forms, each with its own mechanism...
1.5K
Inhaled Medications01:23

Inhaled Medications

968
Inhaled medications are crucial for managing chronic obstructive pulmonary disease (COPD) and asthma. They are essential for effective treatment and control, ensuring optimal respiratory health and well-being. Inhaled medication delivers drugs directly to the lungs, providing a rapid onset of action and reducing systemic side effects compared to oral or injectable medications. Three primary types of inhalation devices are used to administer these medications: nebulizers, metered-dose inhalers...
968

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

EBP Beliefs, Competencies, Implementation Self-Efficacy, and Access to Mentors in a Large U.S. Healthcare System: An Updated Assessment of Where We Are Now.

Worldviews on evidence-based nursing·2026
Same author

Student Perceptions of Interprofessional Education Innovation to Address Pain Management and Substance Use: A Qualitative Descriptive Analysis.

Journal of advanced nursing·2026
Same author

Cross-sectional comparison of cannabis use in adults with neuropathic versus non-neuropathic pain.

Frontiers in pain research (Lausanne, Switzerland)·2026
Same author

A National Randomized Controlled Trial Evaluating ASPMN Nurse-Delivered Empowered Relief®.

Pain management nursing : official journal of the American Society of Pain Management Nurses·2025
Same author

Bridging Gaps in Pain Management: A Qualitative Study of Nurse Navigator Roles.

Pain management nursing : official journal of the American Society of Pain Management Nurses·2025
Same author

Evaluating the impact of Apollo Neuroâ„¢ wearable on wellbeing in medical and pharmacy students: A preliminary prospective randomized controlled study.

The American journal of medicine·2025

Related Experiment Video

Updated: Mar 19, 2026

Dry Powder and Nebulized Aerosol Inhalation of Pharmaceuticals Delivered to Mice Using a Nose-only Exposure System
07:28

Dry Powder and Nebulized Aerosol Inhalation of Pharmaceuticals Delivered to Mice Using a Nose-only Exposure System

Published on: April 6, 2017

41.7K

Mepolizumab.

Dennis J Cada, Ross J Bindler, Danial E Baker

    Hospital Pharmacy
    |June 16, 2016
    PubMed
    Summary

    The Formulary Monograph Service provides monthly drug monographs and utilization evaluations for Pharmacy & Therapeutics Committees. This service aids in informed drug selection and management for healthcare facilities.

    Area of Science:

    • Pharmacology
    • Drug Information Services
    • Healthcare Management

    Background:

    • The Formulary Monograph Service delivers essential drug information to healthcare professionals.
    • It supports Pharmacy & Therapeutics Committees in drug evaluation and formulary management.
    • The service includes monographs for new and investigational drugs, plus utilization evaluations.

    Purpose of the Study:

    • To provide timely and comprehensive drug information to subscribers.
    • To support evidence-based decision-making in medication management.
    • To offer customizable resources for healthcare facilities.

    Main Methods:

    • Publication of 5-6 detailed monographs on new or late-phase drugs monthly.
    • Inclusion of 1-page summary monographs for pharmacy and nursing in-services.

    More Related Videos

    Noninvasive Sampling of Mucosal Lining Fluid for the Quantification of In Vivo Upper Airway Immune-mediator Levels
    05:31

    Noninvasive Sampling of Mucosal Lining Fluid for the Quantification of In Vivo Upper Airway Immune-mediator Levels

    Published on: August 7, 2017

    11.1K
    Refined Murine Model of Idiopathic Pulmonary Fibrosis
    07:51

    Refined Murine Model of Idiopathic Pulmonary Fibrosis

    Published on: June 17, 2025

    1.3K

    Related Experiment Videos

    Last Updated: Mar 19, 2026

    Dry Powder and Nebulized Aerosol Inhalation of Pharmaceuticals Delivered to Mice Using a Nose-only Exposure System
    07:28

    Dry Powder and Nebulized Aerosol Inhalation of Pharmaceuticals Delivered to Mice Using a Nose-only Exposure System

    Published on: April 6, 2017

    41.7K
    Noninvasive Sampling of Mucosal Lining Fluid for the Quantification of In Vivo Upper Airway Immune-mediator Levels
    05:31

    Noninvasive Sampling of Mucosal Lining Fluid for the Quantification of In Vivo Upper Airway Immune-mediator Levels

    Published on: August 7, 2017

    11.1K
    Refined Murine Model of Idiopathic Pulmonary Fibrosis
    07:51

    Refined Murine Model of Idiopathic Pulmonary Fibrosis

    Published on: June 17, 2025

    1.3K
  • Provision of a comprehensive drug utilization evaluation/medication use evaluation (DUE/MUE) each month.

    • Main Results:

    • Subscribers receive print and online access to monographs.
    • Customization options are available to meet specific facility needs.
    • A monthly drug class review is now included, with selected reviews published in Hospital Pharmacy.

    Conclusions:

    • The Formulary Monograph Service is a valuable resource for drug information and management.
    • It facilitates informed decisions regarding drug selection and utilization.
    • The service supports continuous learning and operational efficiency in pharmacy departments.